Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Diagnostics Ltd. Announces Filing of Second Amended and Restated MD&A

TheNewsWire October 13, 2021

Ventripoint Diagnostics Ltd. Announces Filing of Amended and Restated Interim Financial Statements and MD&A

TheNewsWire October 1, 2021

Ventripoint Diagnostics Ltd. Announces Upsize to Previously Announced Bought Deal Offering of Units to $7 Millon

TheNewsWire September 28, 2021

IIROC Trading Resumption - VPT

PR Newswire September 28, 2021

Ventripoint Diagnostics Ltd. Announces $5 Million Bought Deal Offering of Units

TheNewsWire September 27, 2021

IIROC Trading Halt - VPT

PR Newswire September 27, 2021

Ventripoint Issues Option Grants to Consultant

TheNewsWire September 17, 2021

Ventripoint Provides Update on Clinical Studies

TheNewsWire September 15, 2021

Ventripoint Provides Update on Growth Initiatives and Sales

TheNewsWire September 14, 2021

Ventripoint Issues Option Grants to Consultants and Reports Options Exercise

TheNewsWire September 7, 2021

Ventripoint Reports Second Quarter 2021 Financial Statements and MD&A

TheNewsWire September 3, 2021

Ventripoint Announces Patent Application for Improved Heart Analysis

TheNewsWire August 9, 2021

Ventripoint Engages Digital257 for Social Media and Investor Relations Services

TheNewsWire July 5, 2021

Ventripoint Issues Option Grants to Consultants and a Director of the Corporation

TheNewsWire July 2, 2021

Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology

TheNewsWire May 21, 2021

Ventripoint update on its Financial Status and on Warrant and Option Exercises

TheNewsWire May 6, 2021

Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+

TheNewsWire May 4, 2021

IIROC Trading Resumption - VPT

Canada NewsWire April 27, 2021

Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices

TheNewsWire April 27, 2021

IIROC Trading Halt - VPT

Canada NewsWire April 26, 2021